Johnson HM, Shimbo D, Abdalla M, Altieri MM, Bress AP, Carter J, et al. 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American college of cardiology/American heart association joint committee. Hypertension. 2025;82:e212–316. https://doi.org/10.1161/HYP.0000000000000249.
Richardson LTC, Vaughan AS, Wright JS, Coronado F. Examining the hypertension control cascade in adults with uncontrolled hypertension in the US. JAMA Netw Open. 2024;7:e2431997 https://doi.org/10.1001/JAMANETWORKOPEN.2024.31997.
Article PubMed PubMed Central Google Scholar
Ku E, Lee BJ, Wei J, Weir MR. Hypertension in CKD: core curriculum 2019. Am J Kidney Dis. 2019;74:120–31. https://doi.org/10.1053/j.ajkd.2018.12.044.
High Blood Pressure and Chronic Kidney Disease | National Kidney Foundation. [cited 2025 Dec 14]. https://www.kidney.org/high-blood-pressure-and-chronic-kidney-disease.
Hill GS. Hypertensive nephrosclerosis. Curr Opin Nephrol Hypertens. 2008;17:266–70. https://doi.org/10.1097/MNH.0B013E3282F88A1F.
Qasim H, Ktaifan M, Awawdeh A, Khattab K, Leoni MLG, Varrassi G. Hypertensive nephrosclerosis: pathological changes and overlap with diabetic nephropathy. Cureus. 2025;17:e92949 https://doi.org/10.7759/cureus.92949.
Article PubMed PubMed Central Google Scholar
Faheem MSBin, Masood MB, Rehman A, Cheema S, Mughal HMKA, Ahmed F, et al. Mortality trends of renal diseases due to hypertension in adults: an analysis of gender, race, place of death, and geographical disparities in the United States from 1999–2020. Int Urol Nephrol. 2025;57:2995–3008. https://doi.org/10.1007/S11255-025-04493-3.
Sica DA. The kidney and hypertension: causes and treatment. J Clin Hypertension. 2008;10:541 https://doi.org/10.1111/J.1751-7176.2008.08189.X.
Marín R, Gorostidi M, Fernández-Vega F, Álvarez-Navascués R. Systemic and glomerular hypertension and progression of chronic renal disease: the dilemma of nephrosclerosis. Kidney Int. 2005;68(SUPPL. 99):S52–6. https://doi.org/10.1111/j.1523-1755.2005.09910.x.
Faheem MSBin, Masood MB, Rehman A, Cheema S, Mughal HMKA, Ahmed F, et al. Mortality trends of renal diseases due to hypertension in adults: an analysis of gender, race, place of death, and geographical disparities in the United States from 1999 to 2020. Int Urol Nephrol. 2025;57:2995–3008. https://doi.org/10.1007/s11255-025-04493-3.
Cuschieri S. The STROBE guidelines. Saudi J Anaesth. 2019;13:S31–4. https://doi.org/10.4103/SJA.SJA_543_18.
Article PubMed PubMed Central Google Scholar
Multiple Cause of Death, 1999-2020 Request. [cited 2025 Dec 14]. https://wonder.cdc.gov/mcd-icd10.html.
Aggarwal R, Chiu N, Loccoh EC, Kazi DS, Yeh RW, Wadhera RK. Rural-Urban disparities: diabetes, hypertension, heart disease, and stroke mortality among black and white adults, 1999-2018. J Am Coll Cardiol. 2021;77:1480–1. https://doi.org/10.1016/J.JACC.2021.01.032.
Article PubMed PubMed Central Google Scholar
Ingram DD, Franco SJ 2013 NCHS urban-rural classification scheme for counties. Vital Health Stat 2. 2014;2:1–73.
Hoyert DL, Anderson RN. Age-adjusted death rates: trend data based on the year 2000 standard population. Natl Vital Stat Rep. 2001;49:1–6.
Kohagura K, Zamami R, Oshiro N, Shinzato Y, Uesugi N. Heterogeneous afferent arteriolopathy: a key concept for understanding blood pressure–dependent renal damage. Hypertension Res. 2024;47:3383 https://doi.org/10.1038/S41440-024-01916-Z.
Durante A, Mazzapicchi A, Redaelli MB, Durante A, Mazzapicchi A, Redaelli MB. Systemic and cardiac microvascular dysfunction in hypertension. Int J Mol Sci. 2024;25:13294 https://doi.org/10.3390/IJMS252413294.
Article PubMed PubMed Central CAS Google Scholar
Nephrosclerosis: Background, Pathophysiology, Epidemiology. [cited 2025 Dec 14]. https://emedicine.medscape.com/article/244342-overview?form=fpf.
Schelling JR. Tubular atrophy in the pathogenesis of chronic kidney disease progression. Pediatr Nephrol. 2016;31:693–706. https://doi.org/10.1007/S00467-015-3169-4.
Costantino VV, Gil Lorenzo AF, Bocanegra V, Vallés PG. Molecular mechanisms of hypertensive nephropathy: renoprotective effect of losartan through Hsp70. Cells. 2021;10:3146 https://doi.org/10.3390/CELLS10113146.
Article PubMed PubMed Central CAS Google Scholar
Johnson RJ, Segal MS, Srinivas T, Ejaz A, Mu W, Roncal C, et al. Essential hypertension, progressive renal disease, and uric acid: A pathogenetic link? J Am Soc Nephrology. 2005;16:1909–19. https://doi.org/10.1681/ASN.2005010063.
Kanzaki G, Tsuboi N, Haruhara K, Koike K, Ogura M, Shimizu A, et al. Factors associated with a vicious cycle involving a low nephron number, hypertension and chronic kidney disease. Hypertension Res. 2015;38:633–41. https://doi.org/10.1038/HR.2015.67.
Ameer OZ. Hypertension in chronic kidney disease: what lies behind the scene. Front Pharmacol. 2022;13:949260 https://doi.org/10.3389/FPHAR.2022.949260.
Article PubMed PubMed Central CAS Google Scholar
Venditti V, Bleve E, Morano S, Filardi T. Gender-Related factors in medication adherence for metabolic and cardiovascular health. Metabolites. 2023;13:949260 https://doi.org/10.3390/METABO13101087.
Vallon V, Verma S. Effects of SGLT2 inhibitors on kidney and cardiovascular function. Annu Rev Physiol. 2021;83:503–28. https://doi.org/10.1146/ANNUREV-PHYSIOL-031620-095920.
Article PubMed CAS Google Scholar
Toth-Manikowski SM, Yang W, Appel L, Chen J, Deo R, Frydrych A, et al. Sex differences in cardiovascular outcomes in CKD: findings from the CRIC study. Am J Kidney Dis. 2021;78:200–209.e1. https://doi.org/10.1053/J.AJKD.2021.01.020.
Article PubMed PubMed Central CAS Google Scholar
Weldegiorgis M, Woodward M. The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis. BMC Nephrol. 2020;21:506 https://doi.org/10.1186/S12882-020-02151-7.
Article PubMed PubMed Central Google Scholar
Lombardi G, Ferraro PM, De Tomi E, Bargagli M, Spasiano A, Gambaro G. Sex differences in chronic kidney disease–related complications and mortality across levels of glomerular filtration rate. Nephrology Dialysis Transplant. 2024;39:2005–15. https://doi.org/10.1093/NDT/GFAE087.
Damianaki A, Hendriks-Balk M, Brito W, Polychronopoulou E, Theiler K, Pruijm M, et al. In patients with hypertension, the cortical perfusion index measured by contrast enhanced ultrasound reveals a sexual dimorphism. J Am Heart Association: Cardiovascular Cerebrovasc Dis. 2025;14:e039306 https://doi.org/10.1161/JAHA.124.039306.
Balafa O, Balafa O, Fernandez-Fernandez B, Ortiz A, Dounousi E, Ekart R, et al. Sex disparities in mortality and cardiovascular outcomes in chronic kidney disease. Clin Kidney J. 2024;17:44 https://doi.org/10.1093/CKJ/SFAE044.
Grobman B, Turkson-Ocran RA, Zhang M, Juraschek SP. Socioeconomic status and chronic kidney disease among black and white adults: an analysis of 2017-2020 NHANES. Kidney Med. 2025;7:101045 https://doi.org/10.1016/J.XKME.2025.101045.
Article PubMed PubMed Central Google Scholar
Robinson TW, Freedman BI. The impact of APOL1 on chronic kidney disease and hypertension. Adv Chronic Kidney Dis. 2019;26:131–6. https://doi.org/10.1053/j.ackd.2019.01.003.
Article PubMed PubMed Central Google Scholar
Raja A, Raja S, Amin SB, Salman M, Azeem B, Kumar L. Temporal trends in hypertension related end stage renal disease mortality rates: an analysis of gender, race/ethnicity, and geographic disparities in the United States. Front Nephrology. 2023;3:1339312 https://doi.org/10.3389/FNEPH.2023.1339312/BIBTEX.
Chang CH, Fan PC, Kuo G, Lin YS, Tsai TY, Chang SW, et al. Infection in advanced chronic kidney disease and subsequent adverse outcomes after dialysis initiation: a nationwide cohort study. Sci Rep. 2020;10:2938
Comments (0)